Tag: Insulin pumps

SAN DIEGO – Tandem Diabetes Care, has published the result of a meta-analysis of three randomized controlled trials of its Control-IQ advanced hybrid closed-loop technology. The results, published in Diabetes Technology & Therapeutics demonstrate the positive clinical impact of the system’s automatic correction bolusing on glucose control across a wide range of ages and demographics of people with Type 1 diabetes. People with the highest baseline blood sugar levels experienced the greatest...

I’m on information overload this week and it’s only Wednesday. And it’s technology information that I’m being inundated with. It’s exhausting.  Take work. We are switching to new laptops. This is a good thing. But in the lead up to the big switch, I had to start backing up my files differently (In the air! Somewhere!). Now, I’m not a Luddite, by any means, but some concepts are a tad bit harder for me to wrap my mind around. I have a perfectly serviceable...

NEW ORLEANS -With the national mail-order program for diabetes testing supplies drastically changing the marketplace, provider Cynthia Pazos made a deliberate shift toward insulin pumps and other advanced diabetes therapies in 2016—and hasn't looked back. “The way we conduct business—the high quality, high-touch service we give—was more conducive to being able to service patients who use insulin pumps than it was to service patients using test strips,” said Pazos,...

LOS ANGELES - With its recent acquisition of Mini Pharmacy, Angeles Equity Partners has a platform to serve a growing diabetes population, says a spokesman for the private equity firm.Mini, which was launched in 1980 and has been led by the Fox family, specializes in diabetes supplies, insulin pumps and continuous glucose monitors, and also offers enteral nutrition and disposable medical supplies, primarily to the California market.“Mini has a great reputation in the market and is well known...

SAN DIEGO - Medical Device maker Tandem Diabetes Care has inked distribution agreements with Australasian Medical & Scientific Ltd (AMSL) and New Zealand Medical & Scientific Ltd (NZMS) to distribute Tandem's t:slim X2 Insulin Pump in Australia and New Zealand, respectively. “Partnering with key international distributors furthers our mission to expand available insulin pump choices for people with diabetes worldwide,” said Kim Blickenstaff, president and CEO of Tandem Diabetes Care....

BILLERICA, Mass. - Insulet Corp. reported revenue of $130.5 million for the fourth quarter of 2017, an increase of 26% compared to the same period in 2016. U.S. revenue from the Omnipod was $76.5 million, an increase of 21%. Full-year revenue was $463.8 million and U.S. revenue from the Omnipod was $271.6 million. Among Insulet's highlights for 2017: It received Medicare coverage under the prescription drug benefit for the Omnipod, paving the way to capturing an additional one-third of the U.S. market;...

YARMOUTH, Maine - UnitedHealthcare's recent decision to only cover insulin pumps provided by Medtronic is bad news all around, say industry stakeholders.In May, the insurance giant announced it had inked an agreement with the medical device maker to serve as exclusive provider of insulin pumps to its members.“To take away beneficiary choice over economics is not a good thing,” said Dan Gooch, owner of Pal-Med in Columbia, S.C., which offers pumps from Medtronic, Animas and Tandem. “I...

CHICAGO - A recent survey by the American Association of Diabetes Educators found that beneficiary access to insulin pumps and supplies in Round 1 bid areas is “a little worse than expected.” “From our perspective, we figured there'd be some element of access issues, but it was a little worse than what we expected,” said James Specker, director of federal and state advocacy for the AADE. Insulin pumps and supplies were included in a new infusion category as part...

CHICAGO - Contract suppliers aren't making insulin pumps and replacement supplies available to Medicare beneficiaries in competitive bidding areas, says the American Association of Diabetes Educators. The AADE surveyed 29 suppliers in the nine initial CBAs to ask about the availability of specific brands and models of insulin pumps and supplies. Of those suppliers, only 17 (58%) reported carrying insulin pumps and only 18 (62%) reported carrying replacement supplies. Of those who offer insulin...

BEDFORD, Mass. - Insulet, a provider of insulin pumps for patients with diabetes, reported $58.7 million in revenues for the fourth quarter of 2012, a 23% increase over the same period in 2011. It reported net losses of $10.2 million vs. $14.3 million. For all of 2012, Insulet reported revenues of $211.4 million, up from $152.3 million in 2011, and net losses of $51.9 million vs. $45.8 million. The increase in revenues was fueled by continued growth of the customer base, both domestically and...